CEO of techbio company @kantify - AI against rare diseases and cancer

Joined January 2012
137 Photos and videos
Look at this smile 🎈
15 May 2025
Today "a milestone in the evolution of personalized therapies for rare & ultra-rare inborn errors of metabolism" —the 1st human to undergo custom genome editing —outgrowth of decades of NIH funded research nejm.org/doi/full/10.1056/NE… nejm.org/doi/full/10.1056/NE… @NEJM nytimes.com/2025/05/15/healt…
51
Ségolène Martin retweeted
15 May 2025
Today "a milestone in the evolution of personalized therapies for rare & ultra-rare inborn errors of metabolism" —the 1st human to undergo custom genome editing —outgrowth of decades of NIH funded research nejm.org/doi/full/10.1056/NE… nejm.org/doi/full/10.1056/NE… @NEJM nytimes.com/2025/05/15/healt…
32
611
2,209
170,136
Ségolène Martin retweeted
Have your say ! Call for evidence for the Biotech Act: ec.europa.eu/info/law/better… The biotech sector plays a critical role in several areas of the EU economy. It is research-driven, fast-moving and requires substantial public and private investments.
4
2
97
Insightful 🏷️
12 May 2025
Good news everyone! The unpopular and seemingly irrelevant lecture I give in my health econ class on "Most favored nations agreements" just became prophetically relevant. Bad news everyone! This is a terrible policy. 🧵
24
Ségolène Martin retweeted
12 May 2025
Good news everyone! The unpopular and seemingly irrelevant lecture I give in my health econ class on "Most favored nations agreements" just became prophetically relevant. Bad news everyone! This is a terrible policy. 🧵
Can someone tell me what opinion to have on this
69
302
2,649
953,107
Ségolène Martin retweeted
13 May 2025
Everyone needs to hear this…
70
466
4,617
259,619
Ségolène Martin retweeted
ANY foreign clinical trial site that's part of NIH-funded research may be forced to shut down under new 'America First'-driven policy: statnews.com/2025/05/02/nih-…
1
3
3
8,956
Ségolène Martin retweeted
The NeurIPS 2025 Creative AI Track is now inviting research papers and artworks that explore cutting edge applications of AI and ML in art, design, and creative practice. This year, we welcome submissions on the theme of "Humanity". Read more in our Call for Creative AI 2025: neurips.cc/Conferences/2025/…

3
21
72
17,558
Ségolène Martin retweeted
3. Rare Disease (cited 15 and 72 patients worldwide for example) may get approval based on mechanism of action only - then track and follow patients to see if drug works.
5
9
69
17,646
Ségolène Martin retweeted
15 Apr 2025
A smart foreign-born undergrad at a US university asked me if he should go to the UK to start his startup because of the random deportations here. I said that while the median startup wasn't taking things to this extreme yet, it would be an advantage in recruiting.
249
229
4,339
737,942
Ségolène Martin retweeted
3 Apr 2025
No! This photo is not AI edited: a heart-shaped sun ray appeared right during our last team photo!❤️ Meet below a team of people working every day with a lot of ❤️, talent, and AI - to accelerate the discovery of therapies for patients who need them the most.
2
3
88
Ségolène Martin retweeted
What’s a life-saving medical fact everyone should know?
1,975
5,777
62,977
12,387,098
This looks extremely interesting 🤓
12 Feb 2025
We are bringing the last touch to our new Behind The Pill release, where we'll share new Sapian predictions. We will focus on the unknown mechanisms of a drug that everyone knows, but is still largely misunderstood. ✉️Be the first to receive it kantify.com/about-us/newslet…
33
Ségolène Martin retweeted
Today, we at OpenAI launched Deep Researcher and I wanted to share a deeply personal story about how amazing this tool is and how it will change the world. Trigger warning, related to cancer....1/9
257
795
8,036
2,509,360
Ségolène Martin retweeted
29 Jan 2025
Hey Twitter, we are disclosing our biotech pipeline, and there is even a bonus for drug discovery experts. Cancer, Rare Cancers, Rare Neuromuscular disorders, Neurology and Ion Channels are some of our areas of focus.
1
3
4
291
Ségolène Martin retweeted
5 Dec 2024
Can an AI for human drug discovery also excel in plant drug discovery? The answer is yes! This is what our COO @Nico_Maignan explained at his lecture "Unlocking & Accelerating Drug Discovery with Artificial Intelligence: The Kantify Approach." held by our partner @IBMCP 🙏🌿
3
4
249
Ségolène Martin retweeted
Scared to share this after 10 freaking years of waiting but here we go: We found that temperature *perception* can change the next generations, even when “it’s just in the parents' head”. Read how C. elegans neurons control epigenetic inheritance! biorxiv.org/content/10.1101/…
31
87
679
259,803
Huge randomized trial of AI boosts discovery “Teams that were randomly assigned to use the tool discovered 44% more new materials and filed 39% more patent applications than did the ones that stuck to their standard workflow” nature.com/articles/d41586-0…
21
Ségolène Martin retweeted
26 Nov 2024
Today, we're unveiling the latest small molecule drug screened by our AI, Sapian. Many of you are familiar with this medication-it was the 169th most prescribed drug in the United States in 2022, with over 3 million prescriptions. This widely used drug is Diazepam, aka Valium.
1
2
1
137
That’s a very unexpected AI use case theguardian.com/technology/2…

1
21